Skip to main content
Article
Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer
Cancer Chemotherapy and Pharmacology (2004)
  • Robert J. Morgan, City of Hope National Medical Center
  • Timothy W. Synold, City of Hope National Medical Center
  • David Gandara, University of California, Davis
  • Franco Muggia, University of Southern California
  • Sidney Scudder, Hematology and Oncology
  • Eddie Reed, National Institutes of Health
  • Kim Margolin, City of Hope National Medical Center
  • James Raschko, City of Hope National Medical Center
  • Lucille Leong, City of Hope National Medical Center
  • Stephen Shibata, City of Hope National Medical Center
  • Merry Tetef, City of Hope National Medical Center
  • Steven Vasilev, City of Hope National Medical Center
  • Kathryn McGonigle, City of Hope National Medical Center
  • Jeff Longmate, City of Hope National Medical Center
  • Yun Yen, City of Hope National Medical Center
  • Warren Chow, City of Hope National Medical Center
  • George Somlo, City of Hope National Medical Center
  • Mary Carroll, City of Hope National Medical Center
  • James H. Doroshow, City of Hope National Medical Center
Publication Date
October 1, 2004
DOI
10.1007/s00280-004-0818-x
Citation Information
Robert J. Morgan, Timothy W. Synold, David Gandara, Franco Muggia, et al.. "Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer" Cancer Chemotherapy and Pharmacology Vol. 54 Iss. 4 (2004) p. 283 - 289
Available at: http://works.bepress.com/steven-vasilev/13/